Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to spend time with our short people, catch up on sundry chores, and catch up on our reading. And what about you? Once again, we would point out this is a fine time to enjoy the great outdoors. The holidays are nearing, so this may be a good time to open your wallets and help the economy. Or those of you who like to track current events might want to check in to see how the U.S. Constitution is holding up. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon …

Elijah Cummings, the pharma critic-in-chief in Congress, is expected to take the reins of the House Oversight and Government Reform Committee, and will be armed with the authority of a powerful committee chairmanship at a time when lawmakers in both parties are squeezing drug makers more than ever before, STAT writes. The Maryland Democrat will have a high-profile role in the newly Democratic House, and one that will give him the opportunity to haul in executives to demand explanations for price hikes or murky rebate systems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.